CAR T Therapy Is Becoming More Decentralized and Patient Centered – City of Hope
City of Hope shared a post on LinkedIn:
“The delivery of cell therapies is evolving faster than many realize.
CAR T and other cellular treatments are expected to become more decentralized in 2026, with care shifting into outpatient clinics and select home-based settings.
This transition, supported by remote monitoring and digital health, has the potential to significantly reduce hospital stays, lower overall costs and expand access to complex cancer therapies.
Eileen Smith, M.D., the Francis and Kathleen McNamara Distinguished Chair and Professor, Department of Hematology and Hematopoietic Cell Transplantation, outlines how City of Hope‘s model, developing cell therapies on site and delivering care beyond inpatient settings, is helping set a new national standard for patient-centered treatment.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Aug 31, 2026, 15:44Andrea Boccatonda: Special Issue on Pulmonary Embolism and Venous Thromboembolism
-
Aug 31, 2026, 15:41Adrien Jossart: Acute Thrombotic Storm Following Single Heparin Bolus
-
Aug 31, 2026, 15:36Bernhard Gerber: Myocardial Platelet Activation Linked to Microvascular Obstruction After STEMI
-
Aug 31, 2026, 15:34Higher Fibrinogen γ′ Linked to Increased Risk of Recurrent Arterial Thrombosis – Journal of Thrombosis and Haemostasis
-
Aug 31, 2026, 15:21Ney Carter Borges: Anticoagulation Versus Antiplatelet Therapy After TAVI ESC 26
-
Aug 31, 2026, 15:13Nahid A. Qushmaq: MicroRNAs as Prognostic Biomarkers in Septic Patients
-
Aug 31, 2026, 14:32Mahir Khalil Ibrahim Jallo: Hot Topic From The ESC 2026 Munich
-
Aug 31, 2026, 14:28Ruben Mesa: FDA Approves Ropeginterferon Alfa-2b for Essential Thrombocythemia
-
Aug 31, 2026, 14:28Francisco Chacón-Lozsán: Should We Anticoagulate AF Patients With Only One Non-Sex Stroke Risk Factor?